319 related articles for article (PubMed ID: 14645669)
1. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.
Belcheva MM; Tan Y; Heaton VM; Clark AL; Coscia CJ
Mol Pharmacol; 2003 Dec; 64(6):1391-401. PubMed ID: 14645669
[TBL] [Abstract][Full Text] [Related]
2. The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells.
Belcheva MM; Haas PD; Tan Y; Heaton VM; Coscia CJ
J Pharmacol Exp Ther; 2002 Dec; 303(3):909-18. PubMed ID: 12438509
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
[TBL] [Abstract][Full Text] [Related]
4. mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation.
Belcheva MM; Szùcs M; Wang D; Sadee W; Coscia CJ
J Biol Chem; 2001 Sep; 276(36):33847-53. PubMed ID: 11457825
[TBL] [Abstract][Full Text] [Related]
5. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.
Belcheva MM; Clark AL; Haas PD; Serna JS; Hahn JW; Kiss A; Coscia CJ
J Biol Chem; 2005 Jul; 280(30):27662-9. PubMed ID: 15944153
[TBL] [Abstract][Full Text] [Related]
6. Stimulation by vasopressin of ERK phosphorylation and vector-driven water flux in astrocytes is transactivation-dependent.
Du T; Song D; Li H; Li B; Cai L; Hertz L; Peng L
Eur J Pharmacol; 2008 Jun; 587(1-3):73-7. PubMed ID: 18486126
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
8. Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells.
Zhang J; Li H; Wang J; Dong Z; Mian S; Yu FS
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2569-76. PubMed ID: 15277479
[TBL] [Abstract][Full Text] [Related]
9. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells.
Schmidt H; Schulz S; Klutzny M; Koch T; Händel M; Höllt V
J Neurochem; 2000 Jan; 74(1):414-22. PubMed ID: 10617147
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
[TBL] [Abstract][Full Text] [Related]
11. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells.
Andresen BT; Linnoila JJ; Jackson EK; Romero GG
Hypertension; 2003 Mar; 41(3 Pt 2):781-6. PubMed ID: 12623996
[TBL] [Abstract][Full Text] [Related]
12. Ammonia-induced Na,K-ATPase/ouabain-mediated EGF receptor transactivation, MAPK/ERK and PI3K/AKT signaling and ROS formation cause astrocyte swelling.
Dai H; Song D; Xu J; Li B; Hertz L; Peng L
Neurochem Int; 2013 Nov; 63(6):610-25. PubMed ID: 24044899
[TBL] [Abstract][Full Text] [Related]
13. ERK phosphorylation in intact, adult brain by alpha(2)-adrenergic transactivation of EGF receptors.
Du T; Li B; Liu S; Zang P; Prevot V; Hertz L; Peng L
Neurochem Int; 2009 Dec; 55(7):593-600. PubMed ID: 19501623
[TBL] [Abstract][Full Text] [Related]
14. Intracellular transactivation of epidermal growth factor receptor by α1A-adrenoceptor is mediated by phosphatidylinositol 3-kinase independently of activation of extracellular signal regulated kinases 1/2 and serine-threonine kinases in Chinese hamster ovary cells.
Ulu N; Henning RH; Guner S; Zoto T; Duman-Dalkilic B; Duin M; Gurdal H
J Pharmacol Exp Ther; 2013 Oct; 347(1):47-56. PubMed ID: 23902938
[TBL] [Abstract][Full Text] [Related]
15. Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells.
Uchiyama-Tanaka Y; Matsubara H; Mori Y; Kosaki A; Kishimoto N; Amano K; Higashiyama S; Iwasaka T
Kidney Int; 2002 Sep; 62(3):799-808. PubMed ID: 12164862
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.
Flannery PJ; Spurney RF
Nephron Exp Nephrol; 2006; 103(3):e109-18. PubMed ID: 16554661
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Habib AA; Chun SJ; Neel BG; Vartanian T
Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor.
Iwasaki H; Eguchi S; Ueno H; Marumo F; Hirata Y
Endocrinology; 1999 Oct; 140(10):4659-68. PubMed ID: 10499523
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of the mu-opioid receptor regulates agonist intrinsic efficacy.
McLaughlin JP; Chavkin C
Mol Pharmacol; 2001 Jun; 59(6):1360-8. PubMed ID: 11353794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
